Kathy Turner V - 14 Feb 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Senior Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Issuer symbol
IDXX
Transactions as of
14 Feb 2022
Net transactions value
-$149,131
Form type
4
Filing time
16 Feb 2022, 18:28:02 UTC
Previous filing
02 Sep 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +211 +5.1% $0.000000 4,361 14 Feb 2022 Direct F1
transaction IDXX Common Stock Options Exercise $0 +210 +4.8% $0.000000 4,571 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +181 +4% $0.000000 4,752 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +162 +3.4% $0.000000 4,914 14 Feb 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +87 +1.8% $0.000000 5,001 14 Feb 2022 Direct
transaction IDXX Common Stock Tax liability $149,131 -295 -5.9% $505.53 4,706 14 Feb 2022 Direct
holding IDXX Common Stock 100 14 Feb 2022 by spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +3,078 3,078 14 Feb 2022 Common Stock 3,078 $505.53 Direct F3, F11
transaction IDXX Incentive Stock Option (right-to-buy) Award +197 197 14 Feb 2022 Common Stock 197 $505.53 Direct F4, F11
transaction IDXX Restricted Stock Unit Award +371 +19% 2,376 14 Feb 2022 Common Stock 371 Direct F5, F11
transaction IDXX Restricted Stock Unit Options Exercise -211 -8.9% 2,165 14 Feb 2022 Common Stock 211 Direct F6, F11
transaction IDXX Restricted Stock Unit Options Exercise -210 -9.7% 1,955 14 Feb 2022 Common Stock 210 Direct F7, F11
transaction IDXX Restricted Stock Unit Options Exercise -181 -9.3% 1,774 14 Feb 2022 Common Stock 181 Direct F8, F11
transaction IDXX Restricted Stock Unit Options Exercise -162 -9.1% 1,612 14 Feb 2022 Common Stock 162 Direct F9, F11
transaction IDXX Restricted Stock Unit Options Exercise -87 -5.4% 1,525 14 Feb 2022 Common Stock 87 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 19 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021 and December 31, 2021.
F2 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023.
F4 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F5 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2018.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F9 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F10 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F11 Not applicable.